Quest Diagnostics
Clinical laboratory that offers diagnostic testing, services, and information.
Launch date
Employees
Market cap
$17.2b
Enterprise valuation
$22.0b (Public information from Sep 2024)
Share price
$155.48 DGX
Madison Wisconsin (HQ)
Financials
Estimates*
USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 9.4b | 10.8b | 9.9b | 9.3b | 9.6b | 10.1b | 10.5b |
% growth | 22 % | 14 % | (8 %) | (6 %) | 4 % | 6 % | 4 % |
EBITDA | 2.4b | 3.2b | 1.8b | 1.7b | 1.9b | 2.1b | 2.2b |
% EBITDA margin | 26 % | 29 % | 18 % | 19 % | 20 % | 20 % | 21 % |
Profit | 1.4b | 2.0b | 946m | 854m | 888m | 978m | 1.1b |
% profit margin | 15 % | 18 % | 10 % | 9 % | 9 % | 10 % | 10 % |
EV / revenue | 2.0x | 2.3x | 2.2x | 2.1x | 2.2x | 2.1x | 2.0x |
EV / EBITDA | 7.9x | 7.7x | 11.9x | 11.4x | 11.2x | 10.3x | 9.4x |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
* | N/A | $750m | Post IPO Debt |
* | N/A | N/A | Post IPO Debt |
Total Funding | - |
Related Content
Recent News about Quest Diagnostics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit
Investments by Quest Diagnostics
EditACQUISITION by Quest Diagnostics May 2007
ACQUISITION by Quest Diagnostics Apr 2011
ACQUISITION by Quest Diagnostics Oct 2017
ACQUISITION by Quest Diagnostics Jun 2017
exited
ACQUISITION by Quest Diagnostics Jan 2014
ACQUISITION by 23andMe Oct 2021
ACQUISITION by Quest Diagnostics Feb 2007
ACQUISITION by Quest Diagnostics Feb 2017